President Trump’s second term, which began in January 2025, shows no verified signals of voluntary departure, with the president actively advancing policy priorities such as healthcare cost reductions, conducting foreign engagements, and preparing for the 2026 midterms. Trader consensus reflected in the 95.7% “No” price aligns with the absence of imminent catalysts before 2027, reinforced by the historical rarity of presidential resignations and Trump’s public focus on retaining influence through the midterm cycle. Speculation from partisan figures about post-election frustration has not shifted market pricing, as no primary-source developments indicate health, legal, or institutional pressures sufficient to prompt resignation. Realistic factors that could still alter the outcome include confirmed serious health events, substantial congressional losses enabling successful impeachment proceedings, or unanticipated personal decisions, though none currently register as probable within the timeframe.